2024    2023    2022    2021    2020    2019    2018    2017    2016   

2016

Articles avec comité de lecture de revues internationales

21 - 

Insights into the regulation of small RNA expression: SarA represses the expression of two sRNAs in Staphylococcus aureus

Tony Mauro, Astrid Rouillon, Brice Felden

Nucleic Acids Research, 2016, Nucleic Acids Research, 44 (21), pp.10186-10200.

DOI : https://doi.org/10.1093/nar/gkw777

Pubmed : 27596601

 

22 - 

Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis

Lawrence P. Park, Vivian H. Chu, Gail Peterson, Athanasios Skoutelis, Tatjana Lejko-Zupa, Emilio Bouza, Pierre Tattevin, Gilbert Habib, Ren Tan, Javier Gonzalez, Javier Altclas, Jameela Edathodu, Claudio Querido Fortes, Rinaldo Focaccia Siciliano, Orathai Pachirat et al.

Journal of the American Heart Association, 2016, 5 (4), pp.e003016.

DOI : https://doi.org/10.1161/JAHA.115.003016

Pubmed : 27091179

 

23 - 

EuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis

Solene Patrat-Delon, Adrien Rouxel, Arnaud Gacouin, Matthieu Revest, Erwan Flécher, Olivier Fouquet, Yves Le Tulzo, Nicolas Lerolle, Pierre Tattevin, Jean-Marc Tadié

European Journal of Cardio-Thoracic Surgery, 2016, 49 (3), pp.944-951.

DOI : https://doi.org/10.1093/ejcts/ezv223

Pubmed : 26116921

 

24 - 

New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection

Matthieu Revest, C. Jacqueline, R. Boudjemaa, J. Caillon, V. Le Mabecque, A. Breteche, K. Steenkeste, Pierre Tattevin, G. Potel, Christian Michelet, M. P. Fontaine-Aupart, D Boutoille

Journal of Antimicrobial Chemotherapy, 2016, 71 (5), pp.1291-1299.

DOI : https://doi.org/10.1093/jac/dkv496

Pubmed : 26851611

 

25 - 

Adjuvant corticosteroids for patients hospitalized with community-acquired pneumonia: is it time?

Matthieu Revest, Gérald Egmann, Anthony Chapron, Stéphane Jouneau, Pierre Tattevin

Journal of Thoracic Disease, 2016, 8 (5), pp.E288--291.

DOI : https://doi.org/10.21037/jtd.2016.03.34

Pubmed : 27162684

 

26 - 

HACEK endocarditis: state-of-the-art

Matthieu Revest, Gérald Egmann, Vincent Cattoir, Pierre Tattevin

Expert Review of Anti-infective Therapy, 2016, 14 (5), pp.523-530.

DOI : https://doi.org/10.1586/14787210.2016.1164032

Pubmed : 26953488

 

27 - 

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network

M. Rondy, J. Castilla, O. Launay, S. Costanzo, C. Ezpeleta, F. Galtier, K. De Gaetano Donati

Human Vaccines & Immunotherapeutics, 2016, 12 (5), pp.1217--1224.

DOI : https://doi.org/10.1080/21645515.2015.1126013

Pubmed : 27065000

 

28 - 

Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis

Christine Selton-Suty, François Delahaye, Pierre Tattevin, Claire Federspiel, Vincent Le Moing, Catherine Chirouze, Pierre Nazeyrollas, Véronique Vernet-Garnier, Yvette Bernard, Sidney Chocron, Jean-Francois Obadia, François Alla, Bruno Hoen, Xavier Duval

PLoS ONE, 2016, 11 (7), pp.e0158522.

DOI : https://doi.org/10.1371/journal.pone.0158522

Pubmed : 27400273

 

29 - 

Analysis of the 2015 American and European guidelines for the management of infective endocarditis Analyse des recommandations américaines et européennes de 2015 pour la prise en charge des endocardites infectieuses

Pierre Tattevin, Jean-Luc Mainardi

Analysis of the 2015 American and European guidelines for the management of infective endocarditis. Médecine et Maladies Infectieuses, 2016, 46 (8), pp.406-410.

DOI : https://doi.org/10.1016/j.medmal.2016.05.008

Pubmed : 27297743

 

30 - 

Therapeutic drug monitoring of ganciclovir in CMV infections: Should we reassess the therapeutic range?

C. Tron, C. Arnoult, C. Leven, P. Fillatre, C. Pronier, M. Revest, M. C. Verdier, E. Bellissant, F Lemaitre

Fundamental & Clinical Pharmacology, 2016, 30, pp.43.